APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248,001 | -51.7% | 6,519,471 | +15.6% | 0.18% | -50.0% |
| Q2 2023 | $513,702 | +35.2% | 5,638,875 | -2.1% | 0.35% | +28.7% |
| Q1 2023 | $379,974 | +25.8% | 5,760,664 | -1.4% | 0.27% | +17.2% |
| Q4 2022 | $302,124 | -99.9% | 5,842,660 | +5.9% | 0.23% | -22.9% |
| Q3 2022 | $376,752,000 | – | 5,516,123 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,160,000 | $163,403,600 | 25.44% |
| Avoro Capital Advisors LLC | 10,625,000 | $549,418,750 | 8.21% |
| Logos Global Management LP | 1,350,000 | $69,808,500 | 8.18% |
| EcoR1 Capital, LLC | 5,183,431 | $268,035,217 | 8.16% |
| Saturn V Capital Management LP | 212,329 | $9,414,319 | 7.81% |
| ACUTA CAPITAL PARTNERS, LLC | 217,500 | $11,246,925 | 6.92% |
| Ghost Tree Capital, LLC | 300,000 | $15,513,000 | 6.62% |
| Finepoint Capital LP | 334,890 | $17,317 | 5.60% |
| Cormorant Asset Management, LP | 1,576,872 | $81,540 | 5.46% |
| Tri Locum Partners LP | 221,897 | $11,474,000 | 4.64% |